East Bay drug maker tumbles 76% after FDA disses kidney drug
July 20, 2021 at 17:49 PM EDT
The company had originally hoped to win approval of its drug this month.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|